Anna Onisiforou

This study examines time-dependent changes in receptor systems during ethanol withdrawal and links mGlu5R alterations to memory deficits.

VirTarget evaluates MS immunotherapies' effects on EBV-driven dysregulation and host genetics, identifying therapies that reverse or reinforce EBV-MS interactions.

VirTrack identifies EBV's clinical type-specific effects on MS transcriptomes, revealing distinct pathways and proteins involved in disease progression.

This study uses machine learning to identify predictive biomarkers of (2R,6R)-HNK treatment response in opioid-abstinent mice, revealing gene expression changes and context-dependent therapeutic effects.

This study compares Metformin and Semaglutide for Alzheimer's risk reduction in Type II Diabetes using network pharmacology, MR, and transcriptomics, finding Metformin more effective through dual mechanisms.

The paper identifies shared molecular pathways between Type II Diabetes and neuropsychiatric disorders using a network-based approach, highlighting potential therapeutic targets.

This study identifies viral-mediated mechanisms linking specific viruses to Alzheimer's Disease through systems bioinformatics analysis of virus-host protein interactions.

This paper demonstrates that (2R,6R)-hydroxynorketamine reverses maladaptive behaviors and prevents relapse in morphine-abstinent mice by enhancing BDNF and GluN2A signaling.

The paper identifies viral-mediated pathogenic mechanisms in multiple sclerosis using network-based analysis of virus-host and disease-related protein interactions.